Navigating the New Reality: Why Quality and Compliance Are Critical for Biotech’s Future
The biotech sector faces an unprecedented challenge in 2025. As federal funding streams tighten and the post-pandemic landscape reshapes industry priorities, companies must navigate a complex [...]